Healthcare provider profile · identity verified

Janaye Schwartz, M.D.

Family Practice · ALTOONA, PA · NPI 1003471731

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	107
Lisinopril	Lisinopril	281	71
Pantoprazole Sodium	Pantoprazole Sodium	273	61
Gabapentin	Gabapentin	252	61
Amlodipine Besylate	Amlodipine Besylate	224	58
Levothyroxine Sodium	Levothyroxine Sodium	199	53
Omeprazole	Omeprazole	174	49
Metformin Hcl	Metformin Hcl	165	41
Rosuvastatin Calcium	Rosuvastatin Calcium	149	45
Sertraline Hcl	Sertraline Hcl	132	31
Losartan Potassium	Losartan Potassium	119	36
Metoprolol Succinate	Metoprolol Succinate	105	30
Albuterol Sulfate Hfa	Albuterol Sulfate	104	39
Furosemide	Furosemide	100	22
Simvastatin	Simvastatin	100	25
Meloxicam	Meloxicam	95	18
Trazodone Hcl	Trazodone Hcl	93	26
Potassium Chloride	Potassium Chloride	84	24
Eliquis	Apixaban	79	12
Famotidine	Famotidine	79	17
Buspirone Hcl	Buspirone Hcl	78	24
Montelukast Sodium	Montelukast Sodium	74	18
Fluticasone Propionate	Fluticasone Propionate	73	30
Atenolol	Atenolol	64	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	20
Escitalopram Oxalate	Escitalopram Oxalate	62	16
Venlafaxine Hcl Er	Venlafaxine Hcl	60	14
Alendronate Sodium	Alendronate Sodium	59	20
Glipizide Er	Glipizide	59	18
Baclofen	Baclofen	57	13
Alprazolam	Alprazolam	56	13
Ozempic	Semaglutide	56	15
Breo Ellipta	Fluticasone/Vilanterol	50	suppressed
Metformin Hcl Er	Metformin Hcl	50	16
Tramadol Hcl	Tramadol Hcl	50	14
Dicyclomine Hcl	Dicyclomine Hcl	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	47	14
Jardiance	Empagliflozin	47	12
Metoprolol Tartrate	Metoprolol Tartrate	46	suppressed
Xarelto	Rivaroxaban	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	12
Zolpidem Tartrate	Zolpidem Tartrate	44	11
Tamsulosin Hcl	Tamsulosin Hcl	43	12
Midodrine Hcl	Midodrine Hcl	42	suppressed
Trulicity	Dulaglutide	40	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Bupropion Xl	Bupropion Hcl	37	11
Lorazepam	Lorazepam	36	13
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	12
Warfarin Sodium	Warfarin Sodium	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Amoxicillin	Amoxicillin	31	24
Celecoxib	Celecoxib	31	13
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Carvedilol	Carvedilol	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Topiramate	Topiramate	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Naproxen	Naproxen	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Ezetimibe	Ezetimibe	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Spironolactone	Spironolactone	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Cephalexin	Cephalexin	18	18
Glipizide	Glipizide	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Azithromycin	Azithromycin	16	15
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Ketoconazole	Ketoconazole	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Cimetidine	Cimetidine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error